AIDS pathogenesis: The role of accessory gene mutations, leading to formation of long-lived persistently infected cells and/or apoptosis-inducing HIV-1 particles

Virus Research

Volumn 52, Issue 2, 1997, Pages 145-156

  Ikuta, Kazuyoshi ^a   Kameoka, Masanori ^a,c   Luftig, Ronald B ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

AIDS pathogenesis; Apoptosis; Fas system; HIV 1; Nef

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOCOMPETENT CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS LOAD; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0031451932     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00125-1     Document Type: Article

References (110)

1. Ameisen, J.C., Estaquier, J., Idziorek, T., De Bels, F., 1995. The relevance of apoptosis to AIDS pathogenesis. Trends Cell Biol. 5, 27-32.
2. Armad, N., Venkatesan, S., 1988. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485.
3. Bahmani, M.K., Kameoka, M., Nakaya, T., Fujinaga, K., Zhong, Q., Takahashi, H., Nakano, T., Nakai, M., Ueda, S., Jones, I.M., Luftig, R.B., Ikuta, K., 1997. Production of doughnut-shaped, protease-defective particles from a human T cell clone carrying a provirus with specific mutations in the env, pol, vpr, and nef genes. AIDS Res. Hum. Retrov. 13, 523-526.
4. Balter, M., 1996. HIV's other immune-system targets: macrophages. Science 274, 1464-1465.
5. Banda, N.K., Bernier, J., Kurahara, D.K., Kurrle, R., Haigwood, N., Sekaly, R.P., Finkel, T.H., 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176, 1099-1106.
6. Bednarik, D.P., Folks, T.M., 1992. Mechanisms of HIV-1 latency. AIDS 6, 3-16.
7. Bukovsky, A.A., Dorfman, T., Weimann, A., Göttlinger, H.G., 1997. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71, 1013-1018.
8. Bukrinsky, M.I., Stanwick, T.L., Dempsey, M.P., Stevenson, M., 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254, 423-427.
9. Burton, G.F., Masuda, A., Heath, S.L., Smith, B.A., Tew, J.G., Szakal, A.K., 1997. Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunol. Rev. 156, 185-197.
10. + cell model of chronic infection. J. Virol. 65, 4645-4653.
11. Cao, Y., Ho, D.D., Todd, J., Kokka, R., Urdea, M., Lifson, J.D., Piatak, M. Jr., Chen, S., Hahn, B.H., Saag, M.S., Shaw, G.M., 1995. Clinical Evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Res. Hum. Retroviruses 11, 353-361.
12. gag. J. Acq. Imm. Def. Syndr. Hum. Retrov. 10, 1-7.
13. Chen, I.S.Y., 1997. HIV-1 vpr induced cell-cycle arrest and implications for HIV-1 diseases. Symposium presentation, ASM Gen. Mtg., May 5.
14. Chun, T.-W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J.A., Taylor, H., et al., 1997a. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387, 183-188.
15. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI. J. Virol. 71, 4436-4444.
16. Clerici, M., Sarin, A., Coffman, R.L., Wynn, T.A., Blatt, S.P., Hendrix, C.W., et al., 1994. Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91, 11811-11815.
17. Clouse, K.A., Powell, D., Washington, I., Poli, G., Strebel, K., Farrar, W., et al., 1989. Monokine regulation of HIV-1 expression in a chronically infected human T-cell clone. J. Immunol. 142, 431-438.
18. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772-1777.
19. + T-cell repertoire are not immediately restored by antiviral or immune-based therapies. Nature Med. 3, 533-540.
20. Dedera, D., Hu, W., Heyden, N.Y., Ratner, L., 1989. Viral protein R of human immunodeficiency virus type 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J. Virol. 63, 3205-3208.
21. Embretson, J., Zupancic, M., Beneke, J., Till, M., Wolinsky, S., Ribas, J.L., Burke, A., Haase, A.T., 1993. Analysis of human immunodeficiency virus-infected tissues by amplification of in situ hybridization reveals latent and permissive infections at single-cell resolution. Proc. Natl. Acad. Sci. USA 90, 357-361.
22. Fauci, A.S., 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018.
23. Fenyö, E.M., Månson, L.M., Chiodi, F., Lind, B., von Gegerfelt, A., Albert, J., Olausson, F., Åsjö, B., 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62, 4414-4419.
24. Finkel, T.H., Tudor-Williams, G., Banda, N.K., Cotton, M.F., Curiel, T., Monks, C., Baba, T.W., Ruprecht, R.M., Kupfer, A., 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med. 1, 129-134.
25. Fisher, A.G., Ensoli, B., Ivanoff, L., Chamberlain, M., Petteway, S., Ratner, L., Gallo, R.C., Wong-Staal, F., 1987. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237, 888-893.
26. Folks, T., Justement, J., Kinter, A., Dinarello, C.A., Fauci, A.S., 1987. Cytokine induced expression of HIV-1 in a chronically infected promonocytic cell line. Science 238, 800-802.
27. Foster, S., Beverley, P., Aspinall, R., 1995. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor. Eur. J. Immunol. 25, 1778-1782.
28. Fouchier, R.A., Simon, J.H., Jaffe, A.B., Malim, M.H., 1996. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70, 8263-8269.
29. Freund, J., Kellner, R., Konvalinka, J., Wolber, V., Kräusslich, H.-G., Kalbitzer, H.R., 1994. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223, 589-593.
30. Fujinaga, K., Zhong, Q., Nakaya, T., Kameoka, M., Meguro, T., Yamada, K., Ikuta, K., 1995. Extracellular Nef protein regulates productive HIV-1 infection from latency. J. Immunol. 155, 5289-5298.
31. Fujinaga, K., Nakamura, Y., Zhong, Q., Nakaya, T., Ikuta, K., 1996. Growth dominance of a revertant virus generated during in vitro serial passage of nef frameshift mutant of HIV-I. Biochem. Biophy. Res. Commun. 229, 96-101.
32. Gaynor, R., 1992. Cellular transcription factors involved in the regulation of HIV-I gene expression. AIDS 6, 347-363.
33. Gougeon, M.-L., Garcia, S., Heeney, J., Tschopp, R., Lecoeur, H., Guetard, D., Rame, V., Dauguet, C., Montagnier, L., 1993. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retrov. 9, 553-563.
34. Gougeon, M.-L., Lecoeur, H., Dulioust, A., Enouf, M.-G., Crouvoisier, M., Goujard, C., Debord, T., Montagnier, L., 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156, 3509-3520.
35. Groenink, M., Fouchier, R.A.M., de Goede, R.E.Y., de Wolf, F., Gruters, R.A., Cuypers, H.T.M., Huisman, H.G., Tersmette, M., 1991. Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual. J. Virol. 65, 1968-1975.
36. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175, 331-340.
37. Heinzinger, N.K., Bukrinsky, M.I., Haggerty, S.A., Ragland, A.M., Kewalramani, V., Lee, M.-A., et al., 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. 91, 7311-7315.
38. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., Markowitz, M., 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
39. Hoch, J., Lang, S.M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Dittmer, U., et al., 1995. Vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys. J. Virol. 69, 4807-4813.
40. Ikuta, K., Morita, C., Nakai, M., Yamamoto, N., Kato, S., 1988. Defective human immunodeficiency virus (HIV) particles produced by cloned cells of HTLV-1-carrying MT-4 cells persistently infected with HIV. Jpn. J. Cancer Res. 79, 418-423.
41. Jamieson, B.D., Aldrovandi, G.M., Planelles, V., Jowett, J.B.M., Gao, L., Bloch, L.M., Chen, I.S.Y., Zack, J.A., 1994. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68, 3478-3485.
42. Kameoka, M., Kimura, T., Zheng, Y.-H., Suzuki, S., Fujinaga, K., Luftig, R.B., Ikuta, K., 1997a. Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells. J. Clin. Microbiol. 35, 41-47.
43. + killer cells in a small subset, leading to induction of apoptosis in bystander cells. Int. Immunol. 9, 1453-1462.
44. Katsikis, P.D., Wunderlich, E.S., Smith, C.A., Herzenberg, L.A., Herzenberg, L.A., 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036.
45. Kestler, H.W. III, Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Daniel, M.D., Desrosiers, R.C., 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
46. Kirchhoff, F., Greenough, T.C., Brettler, D.B., Sullivan, J.L., Desrosiers, R.C., 1995. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. New Engl. J. Med. 332, 228-232.
47. Kishi, M., Nishino, Y., Sumiya, M., Ohki, K., Kimura, T., Goto, T., Nakai, M., Kakinuma, M., Ikuta, K., 1992. Cells surviving infection by human immunodeficiency virus type 1 (HIV-1): vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. J. Gen. Virol. 73, 77-87.
48. Kishi, M., Nishino, Y., Ohki, K., Kimura, T., Ikuta, K., 1993. Persistently human immunodeficiency virus type 1-infected T cell clone expressing only doubly spliced mRNA exhibits reduced cell surface CD4 expression. Jpn. J. Cancer Res. 84, 153-162.
49. Kishi, M., Tokunaga, K., Zheng, Y.-H., Bahmani, M.K., Kakinuma, M., Nonoyama, M., Lai, P.K., Ikuta, K., 1995a. Superinfection of a defective human immunodeficiency virus type-1 provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination. AIDS Res. Hum. Retrov. 11, 45-53.
50. Kishi, M., Zheng, Y.-H., Bahmani, M.K., Tokunaga, K., Takahashi, H., Kakinuma, M., et al., 1995b. Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J. Virol. 69, 7507-7518.
51. Klimkait, T., Strebel, K., Hoggan, M.D., Martin, M.A., Orenstein, J.M., 1990. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J. Virol. 64, 621-629.
52. Knight, S.C., 1996. Bone-marrow-derived dendritic cells and the pathogenesis of AIDS. AIDS 10, 807-817.
53. Lang, S.M., Weeger, M., Stahl-Hennig, C., Coulibaly, C., Hunsmann, G., Muller, J., et al., 1993. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus. J. Virol. 67, 902-912.
54. Levy, J.A., 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev. 57, 183-289.
55. Levy, J.A., 1994. HIV and AIDS pathogenesis. ASM Press, Washington, D.C., Vol. 359.
56. Levy, D.N., Refaeli, Y., MacGregor, R.R., Weiner, D.B., 1994. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873-10877.
57. Levy, D.N., Refaeli, Y., Weiner, D.B., 1995. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69, 1243-1252.
58. + T cells from HIV-infected persons. J. Immunol. 153, 412-420.
59. Li, C.J., Friedman, D.J., Wang, C., Metelev, V., Pardee, A.B., 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science 268, 429-431.
60. Luciw, P.A., Cheng-Mayer, C., Levy, J.A., 1987. Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication. Proc. Natl. Acad. Sci. USA 84, 1434-1438.
61. Luftig, R.B., Ikuta, K., 1994. Are defective, HIV protease-deficient particles the real culprit in AIDS?. ASM News 60, 417-419.
62. Luftig, R.B., Ikuta, K., Bu, M., Calkins, P., 1990. In: Pearl, L.H. (Ed.), Retroviral Proteases: Control of Maturation and Morphogenesis, MacMillan, London, pp. 141-148.
63. Mahalingam, S., Collman, R.G., Patel, M., Monken, C.E., Srinivasan, A., 1995. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. Virology 212, 331-339.
64. Maldarelli, F., Sato, H., Berthold, E., Orenstein, J., Martin, M.A., 1995. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69, 6457-6465.
65. + T cells in vitro. Differential induction of apoptosis in these cells. J. Immunol. 152, 330-342.
66. McCune, J.M., 1995. Viral latency in HIV disease. Cell 82, 183-188.
67. McNearney, T., Hornickova, Z., Markham, R., Birdwell, A., Arens, M., Saah, A., Ratner, L., 1992. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proc. Natl. Acad. Sci. USA 89, 10247-10251.
68. Meyaard, L., Otto, S.A., Jonker, R.R., Mijnster, M.J., Keet, R.P.M., Miedema, F., 1992. Programmed death of T cells in HIV-1 infection. Science 257, 217-219.
69. Michael, N.L., Mo, T., Merzouki, A., O'Shaughnessy, M., Oster, C., Burke, D.S., et al., 1995. Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J. Virol. 69, 1868-1877.
70. Miller, M.D., Warmerdam, M.T., Gaston, I., Greene, W.C., Feinberg, M.B., 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113.
71. Miller, M.D., Warmerdam, M.T., Page, K.A., Feinberg, M.B., Greene, W.C., 1995. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69, 579-584.
72. Muro-Cacho, C.A., Pantaleo, G., Fauci, A.S., 1995. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154, 5555-5566.
73. Nabel, G.J., 1993. The role of cellular transcription factors in the regulation of human immunodeficiency virus gene expression. In: Cullen, B.R. (Ed.), Human Retroviruses, IRL. press, Oxford, pp. 49-73.
74. Nakaya, T., Fujinaga, K., Kishi, M., Oka, S., Kurata, T., Jones, I.M., Ikuta, K., 1994. Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells. FEBS Lett. 354, 17-22.
75. Nakaya, T., Fujinaga, K., Doi, H., Suzuki, S., Takahashi, H., Nishino, Y., Kishi, M., Azuma, I., Luftig, R.B., Ikuta, K., 1996. Serial passage of human immunodeficiency virus type 1, generates misalignment deletions in non-essential accessory genes. Virus Res. 46, 139-147.
76. Nishino, Y., Kishi, M., Sumiya, M., Ogawa, K., Adachi, A., Maotani-Imai, K., Kato, S., Hirai, K., Ikuta, K., 1991. Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells. Arch. Virol. 120, 181-192.
77. Nishino, Y., Nakaya, T., Fujinaga, K., Kishi, M., Azuma, I., Ikuta, K., 1994. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus. J. Gen. Virol. 75, 2241-2251.
78. Ogawa, K., Shibata, R., Kiyomasu, T., Higuchi, I., Kishida, Y., Ishimoto, A., Adachi, A., 1989. Mutational analysis of the human immunodeficiency virus vpr open reading frame. J. Virol. 63, 4110-4114.
79. Ohki, K., Kishi, M., Nishino, Y., Sumiya, M., Kimura, T., Goto, T., Nakai, M., Ikuta, K., 1991. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells. J. AIDS 4, 1233-1240.
80. + T cells. J. Immunol. 153, 5826-5837.
81. Oyaizu, N., McCloskey, T.W., Coronesi, M., Chirmule, N., Pahwa, S., 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82, 3075-3080.
82. Pandori, M.W., Fitch, N.J.S., Craig, H.M., Richman, D.D., Spina, C.A., Guatelli, J.C., 1996. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283-4290.
83. Panteleo, G., Graziosi, C., Demarest, J.F., Butini, L., Montroni, M., Fox, C., et al., 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358.
84. Patterson, B.K., Till, M., Otto, P., Goolsby, C., Furtado, M.R., McBride, L.J., Wolinsky, S.M., 1993. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260, 976-979.
85. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M., Ho, D.D., 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586.
86. Perelson, A.S., Essunger, P., Cao, Y., Vasenen, M., Hurley, A., Saksela, K., Markowitz, M., Ho, D.D., 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387, 188-191.
87. + + mobilization following CD3 stimulation. J. Immunol. 147, 3145-3148.
88. Piatak, M. Jr., Saag, M.S., Yang, L.C., Clark, S.J., Kappes, J.C., Luk, K.C., Hahn, B.H., Shaw, G.M., Lifson, J.D., 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259, 1749-1754.
89. Pomerantz, R.J., Trono, D., Feinberg, M.B., Baltimore, D., 1990. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61, 1271-1276.
90. Pomerantz, R.J., Bagasra, O., Baltimore, D., 1992. Cellular latency of human immunodeficiency virus type 1. Curr. Opin. Immunol. 4, 475-480.
91. Refaeli, Y., Levy, D.N., Weiner, D.B., 1995. The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
92. Rogel, M.E., Wu, L.I., Emerman, M., 1995. The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
93. Roos, M.T., Lange, J.M., DeGoede, R.E., Coutinho, R.A., Schellekens, P.T., Miedema, F., Tersmette, M., 1992. Viral phenotype and immune response in primary human im-munodeficiency virus type 1 infection. J. Inf. Dis. 165, 427-432.
94. Sanchez, G., Xu, X., Chermann, J.-C., Hirsch, I., 1997. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J. Virol. 71, 2233-2240.
95. Schuitemaker, H., Koostra, N.A., Fouchier, R.A.M., Hooibrink, B., Miedema, F., 1994. Productive HIV-1 infection of macrophage restricted to the cell fraction with proliferative capacity. EMBO J. 13, 5929-5936.
96. Schwartz, O., Maréchal, V., Danos, O., Heard, J.-M., 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cells. J. Virol. 69, 4053-4059.
97. Spina, C.A., Kwoh, T.J., Chowers, M.Y., Guatelli, J.C., Richman, D.D., 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123.
98. Strebel, K., Daugherty, D., Cohen, D., Folks, T., Martin, M.A., 1987. The HIV "A" (sor) gene product is essential for virus infectivity. Nature 38, 728-730.
99. Strebel, K., Klimkait, T., Martin, M.A., 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241, 1221-1223.
100. Strebel, K., Klimkait, T., Maidarelli, F., Martin, M.A., 1989. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63, 3784-3791.
101. Tersmette, M., Gruters, R.A., DeWolf, F., DeGoede, R.E.Y., Lange, J.M.A., Schellekens, P.T.A., et al., 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63, 2118-2125.
102. Terwilliger, E.F., 1992. The accessory gene functions of the primate immunity viruses. In: Koff, W.C., Wong-Staal, F., Kennedy, R.C. (Eds.), AIDS Research Reviews, Vol. 2, Marcel Dekker, Inc., New York, pp. 3-27.
103. Terwilliger, E.F., Cohen, E.A., Lu, Y., Sodrosky, J.G., Haseltine, W.A., 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA 86, 5163-5167.
104. von Schwedler, U., Kornbluth, R.S., Trono, D., 1994. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 6992-6996.
105. Wang, B., Ge, Y.C., Palasanthiran, P., Xiang, S.-H., Ziegler, J., Dwyer, D.E., et al., 1996. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. Virology 223, 224-232.
106. Wei, X., Ghosh, S.K., Taylor, M.E., Johnson, V.A., Emini, E.A., Deutsch, P., et al., 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373, 117-122.
107. Welker, R., Kottler, H., Kalbitzer, H.R., Kräusslich, H.-G., 1996. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219, 228-236.
108. Westendrop, M.O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K.-M., Krammer, P.H., 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 375, 497-500.
109. Yang, J.Y., Schwartz, A., Henderson, E.E., 1993. Inhibition of HIV-1 latency reactivation by dehydroepiandrosterone (DHEA) and an analog of DHEA. AIDS Res. Hum. Retrov. 9, 747-754.
110. Yunoki, M., Maotani-Imai, K., Kusuda, H., Motoyama, M., Miyake, S., Imai, H., et al., 1991. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Arch. Virol. 116, 143-158.